Literature DB >> 33169316

The criteria used to justify endotracheal intubation of patients with COVID-19 are worrisome.

Martin J Tobin1.   

Abstract

Entities:  

Year:  2020        PMID: 33169316      PMCID: PMC7652578          DOI: 10.1007/s12630-020-01853-8

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


× No keyword cloud information.
To the Editor, I read with interest the article by Ahmad et al. describing their experience with endotracheal intubation of patients with COVID-19.1 I thank the caregivers for their voluminous clinical work and acknowledge the many physicians who became infected in the course of their actions. Intubation and mechanical ventilation in severe respiratory failure is lifesaving, and few therapies equal its power across the breadth of medicine. Intubation is also associated with numerous life-threatening complications as documented by decades of research. The decision to insert an endotracheal tube is one of the most difficult faced by an intensivist, and I continue to find this a formidable challenge after 45 years of bedside practice. In contrast to weaning from mechanical ventilation, where physiologic tests exist to guide clinical decision-making,2 the decision to insert an endotracheal tube is based on clinical judgement, gestalt, and tacit knowledge.3,4 While various authors list criteria to guide intubation, not one of these has stood the test of rigorous experimental investigation. Ahmad et al. specify protocolized thresholds that guided intubation decisions, and they report values recorded before intubation. The respiratory rate threshold of 25 breaths·min−1 is the expected physiologic response to stimulation of sensory receptors in a patient with a viral respiratory tract infection.5 The standard deviation (SD) of 10 for mean respiratory rate of 31 breaths/minute (before intubation) signifies that many patients had rates that barely exceeded the upper limit of normal. The mean oxygen saturation of 92% before intubation had an SD of 7%, indicating that many patients had saturations of 95% (or higher), which can signify an arterial oxygen tension of up to 200 mmHg.4 Ahmad et al. report a mean (SD) inspired oxygen concentration (FIO2) of 82 (25)% before intubation; these values are inherently inaccurate because FIO2 is totally unknowable in a non-intubated patient.5 Ahmad et al. convey that they intubated patients early “before significant physiologic decompensation.”1 A strategy of preemptive intubation means that patients who will be able to sustain spontaneous ventilation and gas exchange are going to be intubated in the absence of physiological justification and thus exposed unnecessarily to life-threatening complications. They further state that if a patient was considered a suitable candidate for insertion of an endotracheal tube, that consideration represented justification for not using non-invasive ventilation and high-flow nasal oxygen. This statement is distinctly disturbing—a patient’s ability to tolerate a more invasive procedure should not be justification for bypassing a less invasive, but effective, step.
  4 in total

1.  A prospective study of indexes predicting the outcome of trials of weaning from mechanical ventilation.

Authors:  K L Yang; M J Tobin
Journal:  N Engl J Med       Date:  1991-05-23       Impact factor: 91.245

2.  Why COVID-19 Silent Hypoxemia Is Baffling to Physicians.

Authors:  Martin J Tobin; Franco Laghi; Amal Jubran
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

3.  A prospective, observational, cohort study of airway management of patients with COVID-19 by specialist tracheal intubation teams.

Authors:  Imran Ahmad; Jeyanjali Jeyarajah; Ganeshkrishna Nair; Sophie C Ragbourne; Benjamin Vowles; Danny J N Wong; Kariem El-Boghdadly
Journal:  Can J Anaesth       Date:  2020-09-04       Impact factor: 6.713

4.  Basing Respiratory Management of COVID-19 on Physiological Principles.

Authors:  Martin J Tobin
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

  4 in total
  7 in total

1.  Inaccuracy of pulse oximetry in darker-skinned patients is unchanged across 32 years.

Authors:  Martin J Tobin; Amal Jubran
Journal:  Eur Respir J       Date:  2022-06-23       Impact factor: 33.795

2.  Long-Term Acute Care Hospital Outcomes of Mechanically Ventilated Patients With Coronavirus Disease 2019.

Authors:  Marina Saad; Franco A Laghi; John Brofman; Nidhi S Undevia; Hameeda Shaikh
Journal:  Crit Care Med       Date:  2022-02-01       Impact factor: 9.296

3.  Pondering the atypicality of ARDS in COVID-19 is a distraction for the bedside doctor.

Authors:  Martin J Tobin
Journal:  Intensive Care Med       Date:  2021-01-15       Impact factor: 17.440

Review 4.  COVID-19 pneumonia: pathophysiology and management.

Authors:  Luciano Gattinoni; Simone Gattarello; Irene Steinberg; Mattia Busana; Paola Palermo; Stefano Lazzari; Federica Romitti; Michael Quintel; Konrad Meissner; John J Marini; Davide Chiumello; Luigi Camporota
Journal:  Eur Respir Rev       Date:  2021-10-20

5.  Prone positioning might reduce the need for intubation in people with severe COVID-19 - Authors' reply.

Authors:  Miguel Ibarra-Estrada; Jie Li; John G Laffey; Ivan Pavlov; Oriol Roca; Yonatan Perez; Bairbre McNicholas; David Vines; Elsa Tavernier; Stephan Ehrmann
Journal:  Lancet Respir Med       Date:  2021-12       Impact factor: 30.700

6.  Analysis of mobility level of COVID-19 patients undergoing mechanical ventilation support: A single center, retrospective cohort study.

Authors:  Ricardo Kenji Nawa; Ary Serpa Neto; Ana Carolina Lazarin; Ana Kelen da Silva; Camila Nascimento; Thais Dias Midega; Raquel Afonso Caserta Eid; Thiago Domingos Corrêa; Karina Tavares Timenetsky
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

7.  In reply: The criteria used to justify endotracheal intubation of patients with COVID-19 are worrisome.

Authors:  Danny J N Wong; Imran Ahmad; Jeyanjali Jeyarajah; Benjamin Vowles; Sophie Ragbourne; Ganeshkrishna Nair; Kariem El-Boghdadly
Journal:  Can J Anaesth       Date:  2020-11-10       Impact factor: 6.713

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.